Nucleosomes are barriers to RNA Polymerase II (Pol II) transcribing along gene bodies in eukaryotes. We found that a fragile “tailless nucleosome” could be generated to resolve the Pol II pausing ...
Cardiologist Eric Topol has studied “super agers” for years. This is exactly what he eats — and avoids.
Phrasing is "anything but objective," former Journal of the American Medical Association deputy editor says. Harvard-led ...
Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation AwardExpands iNKT platform into ...
Board brings together internationally recognized leaders in immunology, oncology, and translational science to guide next-gen immune-engineering platforms. FORT LAUDERDALE, FL, UNITED STATES, December ...
WELLINGTON, FLORIDA / ACCESS Newswire / January 8, 2026 / Cellev8 Nutrition Inc., (OTCID:CELV) a leader in clinically validated antioxidant and cellular nutrition solutions, proudly announces the ...
Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — Avinasi Labs, an AI-native ...
New human clinical trial proves arginine, an amino acid, can modify plaque formation on teeth, thereby protecting ...
Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced results from a 12-month real-world analysis of members in its GLP-1 companion program. By extending ...
A research team from the Kunming Institute of Zoology (KIZ) of the Chinese Academy of Sciences has demonstrated for the first ...
A San Diego startup may have created what the scientific community has talked about for decades – a kind of universal flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback